SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Silverback Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 4, 2022

NEW YORK, NY / ACCESSWIRE / December 20, 2021 / The following statement is issued by Levi & Korsinsky, LLP:

To: All natural and legal persons who have acquired or otherwise acquired: (a) Silverback Therapeutics, Inc. (“Silverback” or the “Company”) (NASDAQ: SBTX) together Shares in accordance with and / or traceable to documents issued in connection with the company’s IPO on or about December 3, 2020; and / or (b) Silverback Securities between December 3, 2020 and September 10, 2021, both days inclusive. You will hereby be notified that a securities class action has been initiated in the United States District Court for the Western District of Washington. For more information go to:

Silverback Therapeutics, Inc. Loss Submission Form

or contact Joseph E. Levi, Esq. either by email at [email protected] or by phone at (212) 363-7500. There are no costs or obligations for you.

Silverback Therapeutics, Inc. NEWS – SBTX NEWS

CASE DETAILS: According to the lawsuit, throughout the litigation period, defendants made false and / or misleading statements and / or failed to disclose: (i) Silverback’s lead product candidate, SBT6050, which is in a Phase I / Ib clinical trial, a TLR8- Agonist Linker – the payload conjugated to a HER2-targeting monoclonal antibody that targets tumors such as breast, gastric and non-small cell lung cancers was less effective than the company had shown investors; (ii) accordingly, the Company had overestimated the commercial and / or clinical prospects of SBT6050; and (iii) as a result, Defendants’ offer documents and public statements during the Class Action Period were materially inaccurate and / or misleading and did not contain any information required to be disclosed therein.

WHAT THIS MEANS FOR THE SHAREHOLDERS: If you suffered a loss in Silverback you have up January 4, 2022 to request that the court appoint you as the lead plaintiff. Your ability to partake in a recovery does not require you to act as the lead plaintiff.

The story goes on

NO COST TO YOU: If you acquired Silverback as part of the company’s IPO and / or between December 3, 2020 and September 10, 2021, you may be entitled to compensation without paying any out-of-pocket expenses or fees.

PROTECT YOUR FINANCIAL INTERESTS: Fill out this short submission form https://www.zlk.com/pslra-1/silverback-therapeutics-inc-loss-submission-form?wire=1 or call 212-363-7500 to resolve the case with Joseph E. Levi. to discuss, Esq.

WHY LEVI & KORSINSKY: Levi & Korsinsky have a proven record of winning hundreds of millions of dollars worth of cases for shareholders over a period of 20 years. We represent and fight for shareholders who have been disadvantaged by companies.

Levi & Korsinsky is a nationally recognized law firm with offices in New York, California, Connecticut and Washington, DC. The firm’s founding partners, Joseph Levi and Eduard Korsinsky, have represented shareholders and institutional clients for nearly 20 years and have had remarkable results for clients in the US and internationally. The company, with more than 70 employees, is committed to promoting, nurturing and maintaining a culture of diversity, equality and inclusion for employees and those we represent. Our attorneys have extensive experience representing investors in securities disputes with a track record of recovering hundreds of millions of dollars in cases. Levi & Korsinsky was ranked one of the leading securities litigation firms in the United States in the SCAS Top 50 Report by Institutional Shareholder Services (“ISS”) for 7 consecutive years. The SCAS Top 50 Report identifies the leading securities law firms in the country, and year on year ISS has recognized Levi & Korsinsky as the leading class of securities law firm.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

View source version on accesswire.com:
https://www.accesswire.com/678615/SHAREHOLDER-ALERT-Levi-Korsinsky-LLP-Reminds-Shareholders-of-Silverback-Therapeutics-Inc-of-a-Class-Action-Lawsuit-and-a-Lead- Plaintiffs-deadline-from-January-4-2022 – SBTX

Comments are closed.